| Institution: | 1. Interventional Radiology Unit with Integrated Section of Transational Medical Oncology National Cancer Research Centre, Cancer Institute“Giovanni Paolo II”, Bari, Italy;2. Department of Emergencies and Organ Transplantation (DETO)-University of Bari “Aldo Moro”, Italy;3. Department of Biomedical Sciences and Human Oncology, Section of Internal Medicine and Clinical Oncology, University of Bari Medical School, Bari, Italy;4. Department of Prevention and Animal Ealth, ASL BAT, Barletta, Italy;1. Department of Comparative Biomedicine and Food Science, University of Padova, Viale dell''Università 16, 35020 Agripolis, Legnaro, PD, Italy;2. Department of Veterinary Science, University of Torino, Via Leonardo da Vinci 44, 10095 Grugliasco, TO, Italy;3. Clinical Pathology, Department of Pathobiology, University of Veterinary Medicine of Vienna, Veterinärplatz 1, 1210 Vienna, Austria;4. Centro Oncologico Veterinario, via San Lorenzo 1-4, 40037 Sasso Marconi, BO, Italy;1. Department of Clinical Oncology, Pamela Youde Nethersole Eastern Hospital, 3 Lok Man Road, Chai Wan, Hong Kong;2. Oncology Biomarker Development, Genentech Inc., South San Francisco, CA, USA;3. Biometrics, Roche (China) Holding Ltd., Beijing, China;4. Oncology Biomarker Development, Genentech Inc., CH-4070 Basel, Switzerland;1. Department of Radiation Oncology, Cancer Hospital of Fujian Medical University, Fuzhou, Fujian, China;2. Fujian Provincial Key Laboratory of Translational Cancer Medicine, Fuzhou, Fujian, China;3. Shanghai Proton and Heavy Ion Center, Shanghai, China;4. Department of Radiation Oncology, Fudan University, Shanghai Cancer Center, Shanghai, China |
